Dr. Marks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
830 Harrison Ave 3rd FL
Moakley Hematologyoncology
Boston, MA 02118Phone+1 617-638-6428Fax+1 617-638-5756
Education & Training
Pennsylvania State University College of MedicineClass of 2014
Certifications & Licensure
MA State Medical License 2020 - 2026
RI State Medical License 2017 - 2020
PA State Medical License 2014 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 14 citationsRegorafenib with a fluoropyrimidine for metastatic colorectal cancer after progression on multiple 5-FU-containing combination therapies and regorafenib monotherapyEric I Marks, Carlyn Rose C. Tan, Jun Zhang, Lanlan Zhou, Zhaohai Yang
Cancer Biology & Therapy. 2015-11-11 - 1 citationsCorrelation of CEA but not CA 19-9 as serum biomarkers of disease activity in a case of metastatic rectal adenocarcinoma.Eric I Marks, Matthew Brennan, Wafik S. El-Deiry
Cancer Biology & Therapy. 2015-06-05 - 3 citationsA case of heterogeneous sensitivity to panitumumab in cetuximab-refractory colorectal adenocarcinoma metastasesEric I. Marks, Syed Rizvi, Nabeel Sarwani, Zhaohai Yang, Wafik S. El-Deiry
Cancer Biology & Therapy. 2015-02-19
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
